Recent studies suggest that serum glycosylation can be significantly altered in patients after SARS-CoV-2 infection, and the analysis of serum N-glycome might be significant in the surveillance of COVID-19 [ 15 , 16 ].
← all excerpts
The Alterations of Serum N-glycome in Response to SARS-CoV-2 Vaccination.
1
—
—